Structure–activity relationship of antiparasitic and cytotoxic indoloquinoline alkaloids, and their tricyclic and bicyclic analogues

In a series of carbolines, azaindoles and pyrrolo(iso)quinolines, 2-methyl-β-carboline (9) showed the highest in vitro activity (IC 50 = 0.45 μM) against Plasmodium falciparum K1, without apparent cytotoxicity against L6 cells (SI > 1000). Based on the indoloquinoline alkaloids cryptolepine ( 1),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2009-10, Vol.17 (20), p.7209-7217
Hauptverfasser: Van Baelen, Gitte, Hostyn, Steven, Dhooghe, Liene, Tapolcsányi, Pál, Mátyus, Péter, Lemière, Guy, Dommisse, Roger, Kaiser, Marcel, Brun, Reto, Cos, Paul, Maes, Louis, Hajós, György, Riedl, Zsuzsanna, Nagy, Ildikó, Maes, Bert U.W., Pieters, Luc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In a series of carbolines, azaindoles and pyrrolo(iso)quinolines, 2-methyl-β-carboline (9) showed the highest in vitro activity (IC 50 = 0.45 μM) against Plasmodium falciparum K1, without apparent cytotoxicity against L6 cells (SI > 1000). Based on the indoloquinoline alkaloids cryptolepine ( 1), neocryptolepine ( 2), isocryptolepine ( 3) and isoneocryptolepine ( 4), used as lead compounds for new antimalarial agents, a series of tricyclic and bicyclic analogues, including carbolines, azaindoles, pyrroloquinolines and pyrroloisoquinolines was synthesized and biologically evaluated. None of the bicyclic compounds was significantly active against the chloroquine-resistant strain Plasmodium falciparum K1, in contrast to the tricyclic derivatives. The tricyclic compound 2-methyl-2 H-pyrido[3,4- b]indole ( 9), or 2-methyl-β-carboline, showed the best in vitro activity, with an IC 50 value of 0.45 μM against P. falciparum K1, without apparent cytotoxicity against L6 cells (SI > 1000). However, this compound was not active in the Plasmodium berghei mouse model. Structure–activity relationships are discussed and compared with related naturally occurring compounds.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2009.08.057